Common use of Nasdaq Stock Market Clause in Contracts

Nasdaq Stock Market. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act and is listed for trading on the Nasdaq Global Select Market under the symbol “VTYX”. There is no suit, action, proceeding or investigation pending or, to the knowledge of the Company, threatened against the Company by The Nasdaq Stock Market, LLC or the SEC, respectively, to prohibit or terminate the listing of the Common Stock on the Nasdaq Global Select Market or to deregister the Common Stock under the Exchange Act. The Company has taken no action as of the date hereof that is designed to terminate the registration of the Common Stock under the Exchange Act. The Company has not, in the twelve months preceding the date hereof, received any notice from any Person to the effect that the Company is not in compliance with the listing or maintenance requirements of the Nasdaq Global Select Market and the Company is in compliance with all such listing and maintenance requirements.

Appears in 2 contracts

Samples: Stock Purchase Agreement (Ventyx Biosciences, Inc.), Stock Purchase Agreement (Ventyx Biosciences, Inc.)

AutoNDA by SimpleDocs

Nasdaq Stock Market. The issued and outstanding shares of Common Stock is are registered pursuant to Section 12(b) of the Exchange Act and is are listed for trading on the Nasdaq Global Select Market under the symbol “VTYXBDSX”. There The Company is in compliance with all applicable listing requirements of The Nasdaq Stock Market LLC (“Nasdaq”) applicable to the Company. As of the date hereof, there is no suit, action, proceeding or investigation pending or, to the knowledge of the Company, threatened against the Company by The Nasdaq Stock Market, LLC or the SEC, respectively, to prohibit or terminate the listing of the Common Stock on the Nasdaq Global Select Market or to deregister the Common Stock under the Exchange Act. The Company has taken no action as of the date hereof that is designed to terminate the registration of the Common Stock under the Exchange Act. The Company has not, in the twelve months preceding the date hereof, received any notice from any Person to the effect that the Company is not in compliance with the listing or maintenance requirements of the Nasdaq Global Select Market and the Company is in compliance with all such listing and maintenance requirements.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Biodesix Inc), Securities Purchase Agreement (Biodesix Inc)

Nasdaq Stock Market. The issued and outstanding shares of Common Stock is are registered pursuant to Section 12(b) of the Exchange Act and is are listed for trading on the Nasdaq Global Select Market under the symbol “VTYX”GRPH” (it being understood that the trading symbol will be changed in connection with the Merger). There As of the date hereof, there is no suit, action, proceeding or investigation pending or, to the knowledge of the Company, threatened against the Company by The Nasdaq Stock Market, LLC or the SEC, respectively, to prohibit or terminate the listing of the Common Stock on the Nasdaq Global Select Market or to deregister the Common Stock under the Exchange Act. The Company has taken no action as of the date hereof that is designed to terminate the registration of the Common Stock under the Exchange Act. The Company has not, in the twelve months preceding the date hereof, received any notice from any Person to the effect that the Company is not in compliance with the listing or maintenance requirements of the Nasdaq Global Select Market and the Company is in compliance with all such listing and maintenance requirements.

Appears in 1 contract

Samples: Registration Rights Agreement (Graphite Bio, Inc.)

Nasdaq Stock Market. The issued and outstanding shares of Common Stock is are registered pursuant to Section 12(b) of the Exchange Act and is are listed for trading on the Nasdaq Global Select Market under the symbol “VTYXACRV”. There The Company is in compliance with all applicable listing requirements of Nasdaq applicable to the Company. As of the date hereof, there is no suit, action, proceeding or investigation pending or, to the knowledge of the Company, threatened against the Company by The Nasdaq Stock Market, LLC or the SEC, respectively, to prohibit or terminate the listing of the Common Stock on the Nasdaq Global Select Market or to deregister the Common Stock under the Exchange Act. The Company has taken no action as of the date hereof that is designed to terminate the registration of the Common Stock under the Exchange Act. The Company has not, in the twelve months preceding the date hereof, received any notice from any Person to the effect that the Company is not in compliance with the listing or maintenance requirements of the Nasdaq Global Select Market and the Company is in compliance with all such listing and maintenance requirements.

Appears in 1 contract

Samples: Securities Purchase Agreement (Acrivon Therapeutics, Inc.)

AutoNDA by SimpleDocs

Nasdaq Stock Market. The issued and outstanding shares of Common Stock is are registered pursuant to Section 12(b) of the Exchange Act and is are listed for trading on the Nasdaq Global Select Market under the symbol “VTYXIOBT”. There The Company is in compliance with all applicable listing requirements of The Nasdaq Stock Market LLC (“Nasdaq”) applicable to the Company. As of the date hereof, there is no suit, action, proceeding or investigation pending or, to the knowledge of the Company, threatened against the Company by The Nasdaq Stock Market, LLC or the SEC, respectively, to prohibit or terminate the listing of the Common Stock on the Nasdaq Global Select Market or to deregister the Common Stock under the Exchange Act. The Company has taken no action as of the date hereof that is designed to terminate the registration of the Common Stock under the Exchange Act. The Company has not, in the twelve months preceding the date hereof, received any notice from any Person to the effect that the Company is not in compliance with the listing or maintenance requirements of the Nasdaq Global Select Market and the Company is in compliance with all such listing and maintenance requirements.

Appears in 1 contract

Samples: Securities Purchase Agreement (IO Biotech, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.